Carlsmed (CARL) EBITDA Margin (2024 - 2026)
Carlsmed's (CARL) quarterly EBITDA Margin came in at 58.27% in Q2 2026, down 446.0% on a YoY basis from 16.84% in Q2 2025, and down 1.23% quarter-over-quarter from 57.56% in Q1 2026.
Powered by 
Analysis
Carlsmed (CARL) EBITDA Margin (2024 - 2026) Analysis & Trends
Carlsmed (CARL) has reported EBITDA Margin for 3 consecutive years, with 58.27% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin fell 446.0% year-over-year to 58.27%; the trailing twelve-month figure through Jun 2026 stood at 61.09% (up 344.0% YoY), and the FY2025 full-year result was 60.53%, up 2827.0% from the prior year.
- EBITDA Margin eased to 58.27% in Q2 2026 per CARL's latest filing, from 57.56% in the prior quarter.
- Across five years, EBITDA Margin topped out at 49.93% in Q4 2024 and bottomed at 118.01% in Q3 2024.
- Historically, EBITDA Margin has averaged 69.8% across 3 years, with a median of 58.27% in 2026.
- The widest YoY moves for EBITDA Margin: up 5010 bps in 2025, down 1152 bps in 2025.
- Over 3 years, EBITDA Margin stood at 49.93% in 2024, then fell by 23 bps to 61.44% in 2025, then increased by 5 bps to 58.27% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 58.27%, 57.56%, and 61.44% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 30.66% |
| 10 | Carlsmed | 424.72 Mn | 311.42 Mn | 14.54 Mn | -58.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.27% |
| Mar 31, 2026 | -57.56% |
| Dec 31, 2025 | -61.44% |
| Sep 30, 2025 | -69.11% |
| Jun 30, 2025 | -53.81% |
| Mar 31, 2025 | -56.13% |
| Dec 31, 2024 | -49.93% |
| Sep 30, 2024 | -118.01% |
| Jun 30, 2024 | -103.91% |